- December, 2009 | Public-Private Partnership Involving Chlorion on Short-List for Major Grant
- October, 2009 | Key Patent Application Accepted in India, China, Australia and the European Union
- June, 2009 | Chlorion Pharma Welcomes Dr. David Lowe to its Scientific Advisory Board
- January, 2009 | Chlorion's Co-Founders Publish Comprehensive Review of Chloride Modulation as Therapeutic Strategy
- December, 2008 | Chlorion Pharma Inc. Closes a Financing of $4M in Convertible Debt
- November, 2008 | Chlorion Pharma Announces Dr. Franz Hefti as its New Chief Development Officer
- October, 2008 | Dr. Irenej Kianicka Joins Chlorion’s Team as Director of Pharmacology & Toxicology
- July, 2008 | The Scientific Advisory Board of Chlorion Pharma Ratifies CLP-290 as a Candidate for Full Preclinical Development
- March, 2008 | Chlorion appoints Dr. John Andrews and Dr. Terrence Doyle to its Scientific Advisory Board
- January, 2008 | Chlorion elects Mr. Patrick Walsh to its Board of Directors
- December, 2007 | Chlorion welcomes Dr. Franz Hefti to its Scientific Advisory Board
- September, 2007 | Chlorion Pharma selects Dr. Giorgio Attardo as Senior Director of Chemistry & Pharmaceutical Development
- September, 2007 | Chlorion establishes research facility at the Quebec Biotechnology Innovation Centre in Laval, Quebec
- August, 2007 | Chlorion closes lucrative series A1 round of financing
